【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Indolent Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Indolent Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Indolent Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Indolent Lymphoma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Indolent Lymphoma Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Indolent Lymphoma 32
Jan 22, 2014: New drug shows promise in treating indolent non-Hodgkin lymphomas 32
Dec 10, 2013: Studies Evaluating REVLIMID (Lenalidomide) in Lymphoma Presented at ASH 32
Dec 08, 2013: Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent Non-Hodgkin’s Lymphoma 34
Dec 10, 2012: Infinity Pharma Reports IPI-145 Phase I Data Showing Clinical Activity In B-Cell And T-Cell Malignancies At ASH Annual Meeting 35
Aug 17, 2011: Emergent Announces Initiation Of Phase Ib/II Study Of TRU-016 In Combination With Rituximab And Bendamustine In Subjects With Relapsed-Indolent Lymphoma 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Gilead Sciences, Inc. 40
Clinical Trial Overview of Gilead Sciences, Inc. 40
Celgene Corporation 41
Clinical Trial Overview of Celgene Corporation 41
Teva Pharmaceutical Industries Limited 42
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 42
Cell Therapeutics, Inc. 43
Clinical Trial Overview of Cell Therapeutics, Inc. 43
GlaxoSmithKline plc 44
Clinical Trial Overview of GlaxoSmithKline plc 44
Sanofi 45
Clinical Trial Overview of Sanofi 45
Pharmacyclics, Inc. 46
Clinical Trial Overview of Pharmacyclics, Inc. 46
Infinity Pharmaceuticals, Inc. 47
Clinical Trial Overview of Infinity Pharmaceuticals, Inc. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
Clinical Trial Overview of Top Institutes / Government 49
National Cancer Institute 49
Clinical Trial Overview of National Cancer Institute 49
The University of Texas M. D. Anderson Cancer Center 50
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 50
Memorial Sloan Kettering Cancer Center 51
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 51
University of Nebraska 52
Clinical Trial Overview of University of Nebraska 52
Fred Hutchinson Cancer Research Center 53
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 53
Hoag Memorial Hospital Presbyterian 54
Clinical Trial Overview of Hoag Memorial Hospital Presbyterian 54
Massachusetts General Hospital 55
Clinical Trial Overview of Massachusetts General Hospital 55
Beth Israel Deaconess Medical Center 56
Clinical Trial Overview of Beth Israel Deaconess Medical Center 56
Virginia Commonwealth University 57
Clinical Trial Overview of Virginia Commonwealth University 57
Ohio State University Comprehensive Cancer Center 58
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 58
Five Key Clinical Profiles 59
Appendix 151
Abbreviations 151
Definitions 151
Research Methodology 152
Secondary Research 152
About GlobalData 153
Contact Us 153
Disclaimer 153
Source 154
【レポート販売概要】
■ タイトル:低悪性度リンパ腫:世界の臨床試験レビュー(2014年上半期)■ 英文:Indolent Lymphoma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2020CTIDB
■ 調査対象地域:グローバル
- ブロックチェーン・サプライチェーンの世界市場:コンポーネント別(プラットフォーム、サービス)、用途別(スマートコントラクト、支払い・決済、製品トレーサビリティ、在庫監視、コンプライアンス管理、その他)、業種別(小売、製造、食品・飲料、ヘルスケア、石油・ガス、その他)According to a recent report published by Allied Market Research, titled, "Blockchain Supply Chain Market by Component, Application, and Industry Vertical: Global Opportunity Analysis and Industry Forecast, 2018–2025," the global blockchain supply chain market size was valued at $93.16 Million in 2017 and is projected to reach $9,852.91 Million by 2025, growing at a CAGR of 80.2% from 2018 to 2025 …
- スマートホスピタリティの世界市場予測(~2021):ソフトウェア別(ホテル運営管理システム、ホテルビルオートメーションシステム)、サービス別、ホテル種類別、導入モデル別、地域別The smart hospitality market size is expected to grow from USD 5.74 Billion in 2016 to USD 18.11 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 25.8%. The major drivers for upsurge in demand for smart hospitality software and services include growing demand for real-time optimized guest experience management, luring revenue generation & low operational costs, and increasing adoption o …
- バイオ潤滑剤の世界市場分析:原材料別(動物性油、植物性油)、用途別(自動車(自動車用エンジンオイル、ギヤオイル、油圧オイル、トランスミッションフルード、グリース、チェーンソーオイル)、工業用(プロセスオイル、脱型オイル、産業用ギヤオイル、工業用グリース、金属加工用流体)、エンドユーザー別(産業、商業輸送、消費者用自動車)、セグメント予測The global biolubricants market is expected to reach USD 2.92 billion by 2024, according to a new report by Grand View Research, Inc. Increasing passenger car sales in emerging economies is one of the major drivers of industry expansion in recent years. The favorable regulatory framework is expected to encourage the production & consumption of bio-based lubricants over the forecast period. The U.S …
- PEG化タンパク質の世界市場予測:PEG化キット、PEG化試薬The global PEGylated proteins market is expected to USD 1,137.8 Million by 2021 from USD 690.6 Million in 2016, at a CAGR of 10.5% between 2016 and 2021. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circu …
- ファブリー病治療薬の世界市場About Fabry Disease Fabry disease is an inheritable lysosomal storage disease characterized by the excessive accumulation of globotriaosylceramide (GL-3) in lysosomes. It results from a deficiency of a-Gal and can result in symptoms such as fatigue, angiokeratoma, tinnitus, kidney failure, heart disorders, and nervous system problems. Fabry disease results from mutations in the galactosidase (GLA) …
- 世界のMeat市場動向:企業M&A(2014年5月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global meat market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global meat market throughout the month. Additionally, the report provides an overview of all the partnering, allian …
- 掘削ドリルビットの世界市場:ロータリービット、DTHハンマービットThe global mining drill bits market was valued at $1,145,000 thousand in 2018, and is projected to reach $1,711,800 thousand by 2026, growing at a CAGR of 5.1% from 2019 to 2026. Mining drill bits are cutting tools that are used to dig the hole of circular area. These drill bits are deployed to remove rock or debris material to create different size of holes. There are certain specialized mining d …
- 無線・モバイル端末及びOSS:ソリューション及び市場機会:Wireless/Mobile Devices and OSS: Solutions and Market OpportunitiesWireless/Mobile Devices and OSS: Solutions and Market Opportunities is the most comprehensive research package available in the market focusing on wireless/mobile devices including OSS, User Interface (UI), device issues such as Bring Your Own Device (BYOD) and device security/privacy, user behavior and usability. This research covers all major device types including smartphones, tablets, and wear …
- デジタルカメラの世界市場2016-2020About the Digital Camera Market A digital camera is an optical device that captures and stores images and videos in a digital format and can immediately display the stored images or videos. Unlike film cameras, digital cameras provide users with options to download, store, or delete the clicked shots to computer systems or other storage systems like internal and external memory cards. Digital came …
- 産業用電池の世界市場予測(~2021年):鉛電池、ニッケル電池、リチウム電池The industrial batteries market is projected to reach USD 10.84 Billion by 2021, at a CAGR of 6.5% between 2016 and 2021. The growth of the market can be mainly attributed to the growing demand from the automotive sector, growth in the renewable energy sector, increased recycling efficiency of lead-acid and lithium-based industrial batteries, and superior performance of industrial batteries in ter …
- Tango Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Tango Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Tango Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- POC脂質検査の世界市場2017-2021ABSTRACTAbout POC Lipid Testing Point-of-care (POC) lipid testing is used to measure the lipid level of the blood at a convenient place near the patient. The test also measures high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and triglyceride level of the blood. POC tests help reduce the time between the diagnosis and treatment of a disease. They are antibody-based or mi …
- 医用画像解析ソフトウェアの世界市場:タイプ別(スタンドアロン)、画像タイプ別(2D、3D、4D)、モダリティ別(CT、MRI、PET、超音波)、用途別(整形外科、歯科、腫瘍、腎臓疾患)、エンドユーザー別(病院、診断センター、研究)、地域別予測Global Medical image software analysis Market to reach USD 4.9 billion by 2025. Global Medical image software analysis Market valued approximately USD 2.41 billion in 2016 is anticipated to grow with a healthy growth rate of more than 8.1% over the forecast period 2017-2025. Key success factors for this market are; technological advancements in medical imaging systems & analysis software, growing …
- スマートメーターの世界市場予測(~2022年):電力メーター、水道メーター、ガスメーターThe global smart meters market is projected to grow at a CAGR of 9.34% from 2017 to 2022, to reach a market size of USD 19.98 Billion by 2022. This growth can be attributed to the rising investments in smart grid projects and increasing upgradation of transmission & distribution infrastructure, government policies, and energy conservation. The report segments the smart meters market on the basis o …
- 垂直農法の世界市場分析:構造別(出荷コンテナ、建物ベース)、提供別(照明、水耕性成分、気候制御)、栽培方法別(空中栽培、水耕栽培)、セグメント予測、2014-2025The global vertical farming market is anticipated to reach USD 9.9 billion by 2025, according to a new report by Grand View Research, Inc. The increased use of Internet of Things (IoT) sensors, for producing crops, is likely to spur the market demand over the forecast period. The information obtained from the sensors is stored on the cloud and analyzed to perform the required actions. The growing …